20,728 Shares of Baxter International Inc. $BAX Acquired by Cohen Klingenstein LLCDefense World · Oct 16, 2026
Baxter International: The Vantive Transition Complicates Margin RecoverySeeking Alpha · Oct 13, 2026
Financial Contrast: Baxter International (NYSE:BAX) and Omnicell (NASDAQ:OMCL)Defense World · Oct 11, 2026
Baxter to Host Third-Quarter 2026 Financial Results Conference Call for InvestorsBusiness Wire · Oct 7, 2026
Are Investors Undervaluing Baxter International (BAX) Right Now?Zacks Investment Research · Oct 6, 2026
Is Baxter International (BAX) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research · Oct 6, 2026Baxter International Inc., operating globally via its subsidiaries, is a leading developer and provider of a wide spectrum of healthcare products. The company's comprehensive portfolio includes various dialysis treatments, such as peritoneal and hemodialysis, along with related therapies and services. It also specializes in intravenous (IV) therapies, infusion pumps, administration sets, and devices for drug reconstitution.
| Date | Est. | Actual | |
|---|---|---|---|
| Jul 30, 2026 | $0.37 | $0.56 | Beat |
| Apr 30, 2026 | $0.31 | $0.36 | Beat |
| Feb 12, 2026 | $0.53 | $0.44 | Miss |
| Oct 30, 2025 | $0.60 | $0.69 | Beat |
| Jul 31, 2025 | $0.60 | $0.59 | Miss |
| May 1, 2025 | $0.48 | $0.55 | Beat |